Nathan M. Radcliffe, MD
Show Description +
Nathan M. Radcliffe, MD, and his team presented data on the implantation of Durysta (Allergan) into the iridociliary sulcus. He highlights the advantages of this implantation technique and its potential to reduce endothelial cell loss.
Posted: 5/08/2023
Nathan M. Radcliffe, MD
Nathan M. Radcliffe, MD, and his team presented data on the implantation of Durysta (Allergan) into the iridociliary sulcus. He highlights the advantages of this implantation technique and its potential to reduce endothelial cell loss.
Posted: 5/08/2023
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASCRS: 2023.
Please log in to leave a comment.